Report overview
Antipyretic Analgesic Agent are drugs that can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.
This report aims to provide a comprehensive presentation of the global market for Antipyretic Analgesic Anti-Inflammatory Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antipyretic Analgesic Anti-Inflammatory Drugs. This report contains market size and forecasts of Antipyretic Analgesic Anti-Inflammatory Drugs in global, including the following market information:
Global Antipyretic Analgesic Anti-Inflammatory Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Antipyretic Analgesic Anti-Inflammatory Drugs Market Sales, 2018-2023, 2024-2029, (Tons)
Global top five Antipyretic Analgesic Anti-Inflammatory Drugs companies in 2022 (%)
The global Antipyretic Analgesic Anti-Inflammatory Drugs market was valued at US$ 2789.5 million in 2022 and is projected to reach US$ 3123.1 million by 2029, at a CAGR of 1.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Shandong Xinhua Pharmaceutical Company Limited and Mallinckrodt Pharmaceuticals are the top 2 manufacturers of antipyretic and analgesic raw materials globally and holds over 30% of global market share in total. Geographically speaking, North America holds about 25% of total market share, followed by China with over 20% share. In terms of type, paracetamol segment holds over half of total market share, followed by ibuprofen with over 20% share. In terms of end users, adult segment holds a dominant share of over 70%.
We surveyed the Antipyretic Analgesic Anti-Inflammatory Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antipyretic Analgesic Anti-Inflammatory Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Antipyretic Analgesic Anti-Inflammatory Drugs Market Segment Percentages, by Type, 2022 (%)
Paracetamol
Aspirin
Ibuprofen
Naproxen
Diclofenac
Oxaprozin
Dexibuprofen
Others
Global Antipyretic Analgesic Anti-Inflammatory Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Antipyretic Analgesic Anti-Inflammatory Drugs Market Segment Percentages, by Application, 2022 (%)
Adults
Children
Global Antipyretic Analgesic Anti-Inflammatory Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Antipyretic Analgesic Anti-Inflammatory Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antipyretic Analgesic Anti-Inflammatory Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Antipyretic Analgesic Anti-Inflammatory Drugs revenues share in global market, 2022 (%)
Key companies Antipyretic Analgesic Anti-Inflammatory Drugs sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Antipyretic Analgesic Anti-Inflammatory Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mallinckrodt Pharmaceuticals
IOL
Anqiu Lu'an Pharmaceutical
Novacyl
BASF
Anhui BBCA Pharmaceuticals
Hubei Biocause
Xinhua Pharm
Granules India Limited
Huagang Pharm
Hebei Jiheng Pharmaceutical
Zhejiang Kangle Pharmaceutical
Hebei Jingye Medical Technology
MSPF
Lu'an Pharmaceutical
Mallinckrodt
Farmson
Anhui Fubore
SKPL
Atabay
Huzhou Konch Pharmaceutical
Anhui Topsun
SOLARA
SI Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antipyretic Analgesic Anti-Inflammatory Drugs, market overview.
Chapter 2: Global Antipyretic Analgesic Anti-Inflammatory Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Antipyretic Analgesic Anti-Inflammatory Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antipyretic Analgesic Anti-Inflammatory Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Antipyretic Analgesic Anti-Inflammatory Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
